<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Healthcare Industry Today: Anemia Drugs News</title>
<link>http://health.einnews.com/news/anemia-drug</link><description>Constantly updated news and information about healthcare industry.</description><item>
<title>What&apos;s in your water?</title>
<link>http://health.einnews.com/news.php?wid=191785492</link>
<pubDate>7 Oct 2008 01:27 GMT</pubDate>
<description>
...  linked to polluted drinking water&amp;mdash;including stomach illness, anemia, and irreversible damage to the nervous system&amp;mdash;had  ...  give out about $80 million in wastewater treatment assistance across the United States. These efforts  ...  the harsh anonymous comments from readers. To remedy that, we are introducing new features. You  ...
</description>
</item><item>
<title>NIH Launches New Web Site for Parents on Medical Research Studies for Children</title>
<link>http://health.einnews.com/news.php?wid=191740494</link>
<pubDate>6 Oct 2008 21:32 GMT</pubDate>
<description>
...  discussing clinical studies From asthma and cancer treatments to vaccines, research in children saves lives  ...  research on asthma, heart disease, sickle cell anemia, obesity, and other conditions  developed the  ...  their unique research needs is understanding how medications affect the developing child and adolescent, and  ...
</description>
</item><item>
<title>Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children</title>
<link>http://health.einnews.com/news.php?wid=191739298</link>
<pubDate>6 Oct 2008 21:28 GMT</pubDate>
<description>
...  6 /PRNewswire-USNewswire/ -- From asthma and cancer treatments to vaccines, research in children saves lives  ...  research on asthma, heart disease, sickle cell anemia, obesity, and other conditions -- developed the  ...  their unique research needs is understanding how medications affect the developing child and adolescent, and  ...
</description>
</item><item>
<title>Topline Results From Phase III Study Evaluating The Combination Of Avastin And Tarceva As 2nd-Line Treatment For Advanced Non-Small Cell Lung Cancer</title>
<link>http://health.einnews.com/news.php?wid=191722609</link>
<pubDate>6 Oct 2008 20:30 GMT</pubDate>
<description>
...  cancer.&quot; Avastin is currently approved as first-line treatment in combination with carboplatin and paclitaxel chemotherapy  ...  myocardial infarction/ischemia, cerebrovascular accident, and micro-angiopathic hemolytic anemia with thrombocytopenia have occurred. Cases of hepatic  ...  flagship product, Tarceva (erlotinib), is the first drug discovered and developed by OSI to obtain  ...
</description>
</item><item>
<title>--&gt; Copper -- the Metal We Can&apos;t Live Without</title>
<link>http://health.einnews.com/news.php?wid=191718522</link>
<pubDate>6 Oct 2008 20:19 GMT</pubDate>
<description>
...  this growing problem, Oct. 19-25 has been named So how can copper help? Earlier this  ...  in bone abnormalities, impaired growth, weight gain, anemia, frequent infections (colds, flu, pneumonia), poor motor  ...  to the Health Research Institute and Pfeiffer Treatment Center, copper deficiencies may also lead to  ...
</description>
</item><item>
<title>CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn&apos;s Patients</title>
<link>http://health.einnews.com/news.php?wid=191717478</link>
<pubDate>6 Oct 2008 20:17 GMT</pubDate>
<description>
...  of Severity (CDEIS)) within ten weeks of treatment in more than 60 percent of the  ...  was approved by the U.S. Food and Drug Administration on . The approval was based  ...  disorders. Rare reports of pancytopenia, including aplastic anemia, have been reported with TNF blockers. Medically  ...
</description>
</item><item>
<title>Oral Cancer Drug REVLIMID(R) Receives Marketing Authorization from Health Canada for Treatment of Multiple Myeloma</title>
<link>http://health.einnews.com/news.php?wid=191710587</link>
<pubDate>6 Oct 2008 19:30 GMT</pubDate>
<description>
... ) announced that its oral cancer drug REVLIMID (lenalidomide) has received marketing authorization approval  ...  use in combination with dexamethasone as a treatment for patients with multiple myeloma who have  ...  the United States and Argentina for transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated  ...
</description>
</item><item>
<title>Grants To Expand Disease-Focused Stem Cell Research Received By Einstein And Montefiore</title>
<link>http://health.einnews.com/news.php?wid=191685971</link>
<pubDate>6 Oct 2008 17:19 GMT</pubDate>
<description>
...  disease and cancer through groundbreaking stem cell treatments represents the future of medicine, and it  ...  patients with blood diseases like sickle cell anemia and hemophilia. Once we have these stem  ...  that cause the problem or by developing drugs that treat the underlying cause of these  ...
</description>
</item><item>
<title>Pill is safe solution for women over 35</title>
<link>http://health.einnews.com/news.php?wid=191683356</link>
<pubDate>6 Oct 2008 16:59 GMT</pubDate>
<description>
... Pill is safe solution for women over 35  ...  control pill provides a safe and easy treatment option for unacceptable bleeding patterns. It is  ...  ovulation. It reduces blood loss and subsequent anemia. It can help with premenstrual disorders and  ...
</description>
</item><item>
<title>Genentech and OSI Pharmaceuticals Announce Topline Results from Phase III Study Evaluating the Combination of</title>
<link>http://health.einnews.com/news.php?wid=191678697</link>
<pubDate>6 Oct 2008 16:34 GMT</pubDate>
<description>
...  cancer.&quot; Avastin is currently approved as first-line treatment in combination with carboplatin and paclitaxel chemotherapy  ...  myocardial infarction/ischemia, cerebrovascular accident, and micro-angiopathic hemolytic anemia with thrombocytopenia have occurred. Cases of hepatic  ...  flagship product, Tarceva(R) (erlotinib), is the first drug discovered and developed by OSI to obtain  ...
</description>
</item><item>
<title>Genentech and OSI Pharmaceuticals Announce Topline Results from Phase III Study Evaluating the Combination of Avastin and Tarceva as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer</title>
<link>http://health.einnews.com/news.php?wid=191670982</link>
<pubDate>6 Oct 2008 13:56 GMT</pubDate>
<description>
...  cancer.&quot; Avastin is currently approved as first-line treatment in combination with carboplatin and paclitaxel chemotherapy  ...  myocardial infarction/ischemia, cerebrovascular accident, and micro-angiopathic hemolytic anemia with thrombocytopenia have occurred. Cases of hepatic  ...  flagship product, Tarceva(R) (erlotinib), is the first drug discovered and developed by OSI to obtain  ...
</description>
</item><item>
<title>Dialysis firms expand in S. Arizona</title>
<link>http://health.einnews.com/news.php?wid=191609254</link>
<pubDate>6 Oct 2008 03:36 GMT</pubDate>
<description>
...  providers of dialysis, the life-extending blood filtration treatment. Both arrived in Tucson in the last  ...  Epogen, which many nephrologists call a &quot;wonder drug.&quot; Kidneys play a vital role in red  ...  the bloodstream fall and patients can get anemia. Epogen boosts oxygen in the bloodstream and  ...
</description>
</item><item>
<title>Dialysis firms expand here</title>
<link>http://health.einnews.com/news.php?wid=191587791</link>
<pubDate>6 Oct 2008 00:31 GMT</pubDate>
<description>
...  providers of dialysis, the life-extending blood filtration treatment. Both arrived in Tucson in the last  ...  Epogen, which many nephrologists call a &quot;wonder drug.&quot; Kidneys play a vital role in red  ...  the bloodstream fall and patients can get anemia. Epogen boosts oxygen in the bloodstream and  ...
</description>
</item><item>
<title>Saving Babies</title>
<link>http://health.einnews.com/news.php?wid=191578479</link>
<pubDate>5 Oct 2008 23:26 GMT</pubDate>
<description>
...  with inconsistent medical care; three more with anemia; seven with inadequate nutrition. Improving access to  ...  all races can be hesitant to seek treatment, but young black women may feel even  ...  Ashe, who needed help sorting through which medications she was on might harm her developing  ...
</description>
</item><item>
<title>Cost And Value Of Biopharmaceuticals</title>
<link>http://health.einnews.com/news.php?wid=191510103</link>
<pubDate>5 Oct 2008 06:01 GMT</pubDate>
<description>
...  are designed for serious illnesses such as anemia or multiple sclerosis. Because of their uniqueness  ...  category, as anemia is associated with their treatment and conditions for such diseases. Yet, some  ...  is probably why the producers of these drugs can charge so much for these products.  ...
</description>
</item></channel>
</rss>
